價(jià)格 | ¥413 | ¥289 | ¥979 |
包裝 | 100mg | 50mg | 500mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2025-08-20 |
中文名稱(chēng):L-氫化乳清酸 | 英文名稱(chēng):L-Dihydroorotic acid |
CAS:5988-19-2 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice./Shipping at ambient temperature. |
純度規(guī)格: 99.88% | 產(chǎn)品類(lèi)別: 抑制劑 |
貨號(hào): T4880 |
名稱(chēng) | L-Dihydroorotic acid |
描述 | L-Dihydroorotic acid, also known as (S)-4,5-dihydroorotate or dihydro-L-orotate, belongs to the class of organic compounds known as alpha amino acids and derivatives. Within the cell, L-dihydroorotic acid is primarily located in the cytoplasm and mitochondria. L-Dihydroorotic acid exists in all eukaryotes, ranging from yeast to humans. L-Dihydroorotic acid participates in a number of enzymatic reactions. In particular, L-Dihydroorotic acid can be biosynthesized from ureidosuccinic acid; which is catalyzed by the enzyme cad protein. In addition, L-Dihydroorotic acid and quinone can be converted into orotic acid; which is mediated by the enzyme dihydroorotate dehydrogenase (quinone), mitochondrial. In humans, L-dihydroorotic acid is involved in the pyrimidine metabolism pathway. L-Dihydroorotic acid is also involved in several metabolic disorders, some of which include UMP synthase deficiency (orotic aciduria), the mngie (mitochondrial neurogastrointestinal encephalopathy) pathway, Beta ureidopropionase deficiency, and dihydropyrimidinase deficiency. |
存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice./Shipping at ambient temperature. |
溶解度 | DMSO : 50 mg/mL (316.24 mM), Sonication is recommended. |
關(guān)鍵字 | Reversibly | L-ureidosuccinic | L-Dihydroorotic acid | LDihydroorotic acid | L Dihydroorotic acid | Inhibitor | inhibit | hydrolyze | enzyme | EndogenousMetabolite | Endogenous Metabolite | dihydrowhey | acid |
相關(guān)產(chǎn)品 | Formamide | Naringin | Guanidine hydrochloride | Daidzein | Glycerol | Cysteamine hydrochloride | Aceglutamide | Sucrose | Ferulic Acid | 3-Indoleacetic acid | Thymidine | Fumaric acid |
相關(guān)庫(kù) | 微生物天然產(chǎn)物庫(kù) | 經(jīng)典已知活性庫(kù) | 人內(nèi)源代謝化合物庫(kù) Plus | 已知活性化合物庫(kù) | 人內(nèi)源代謝化合物庫(kù) | 小鼠代謝化合物庫(kù) | 腸道微生物代謝化合物庫(kù) | 天然產(chǎn)物庫(kù) | 高溶解性片段庫(kù) | 高通量篩選天然產(chǎn)物庫(kù) | Ro5類(lèi)藥天然產(chǎn)物庫(kù) | 人代謝物化合物庫(kù) |
成立日期 | 2013-04-18 (13年) | 注冊(cè)資本 | 566.2651萬(wàn)人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 化學(xué)試劑,生物活性小分子 | 經(jīng)營(yíng)模式 | 貿(mào)易,試劑,定制,服務(wù) |
產(chǎn)品名稱(chēng) | 價(jià)格 | 公司名稱(chēng) | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢(xún)價(jià) |
VIP2年
|
湖北鴻福達(dá)生物科技有限公司
|
2025-08-20 | |
¥200 |
VIP2年
|
武漢吉業(yè)升化工有限公司
|
2025-08-20 | |
¥120 |
VIP2年
|
西安拉維亞生物科技有限公司
|
2025-08-20 | |
詢(xún)價(jià) |
VIP3年
|
山東愛(ài)采生物科技有限公司
|
2025-08-20 | |
¥110 |
VIP2年
|
武漢吉業(yè)升化工有限公司
|
2025-08-20 | |
詢(xún)價(jià) |
VIP5年
|
武漢華玖醫(yī)藥科技有限公司
|
2025-08-20 | |
¥25 |
VIP6年
|
上??道噬锟萍加邢薰?/div>
|
2025-08-20 | |
¥110 |
VIP2年
|
武漢吉業(yè)升化工有限公司
|
2025-08-20 | |
¥120 |
VIP7年
|
河北創(chuàng)之源生物科技有限公司
|
2025-08-20 | |
¥107 |
VIP2年
|
武漢吉業(yè)升工化有限公司
|
2025-08-20 |